Title :

One Year Assessment of the Hearing Preservation Potential of the EVO Electrode Array.

Author(s) :

Guevara, Nicolas [Auteur]
Institut Universitaire de la Face et du Cou [Nice]
Parietti-Winkler, Cécile [Auteur]
Centre Hospitalier Régional Universitaire de Nancy [CHRU Nancy]
Godey, Benoît [Auteur]
Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Pontchaillou]
Franco-Vidal, Valérie [Auteur]
CHU de Bordeaux Pellegrin [Bordeaux]
Gnansia, Dan [Auteur]
Oticon Medical / Neurelec
Ardoint, Marine [Auteur]
Oticon Medical / Neurelec
Hoen, Michel [Auteur]
Oticon Medical / Neurelec
Karoui, Chadlia [Auteur]
Oticon Medical / Neurelec
Truy, Eric [Auteur]
Département d'ORL, chirurgie cervico-maxillo-faciale et d'audiophonologie [Hôpital Edouard Herriot - HCL]
Vincent, Christophe [Auteur]
Advanced Drug Delivery Systems (ADDS) - U1008
Mosnier, Isabelle [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Nguyen, Yann [Auteur]
CHU Pitié-Salpêtrière [AP-HP]

Journal title :

Journal of Clinical Medicine

Abbreviated title :

J Clin Med

Volume number :

10

Pages :

5604

Publisher :

MDPI

Publication date :

2021-12-14

ISSN :

2077-0383

Keyword(s) :

cochlear implantation
hearing preservation
HEARRING classification
functional hearing
EVO electrode array

HAL domain(s) :

Sciences du Vivant [q-bio]
Sciences du Vivant [q-bio]

English abstract : [en]

Background: A prospective longitudinal multicentre study was conducted to assess the one-year postsurgical hearing preservation profile of the EVOTM electrode array. Methods: Fifteen adults presenting indications of ...
Show more >Background: A prospective longitudinal multicentre study was conducted to assess the one-year postsurgical hearing preservation profile of the EVOTM electrode array. Methods: Fifteen adults presenting indications of electro-acoustic stimulation (pure-tone audiometry (PTA) thresholds ≤70 dB below 750 Hz) were implanted with the EVO™ electrode array. Hearing thresholds were collected at five time-points from CI activation to twelve months (12M) after activation. Hearing thresholds and hearing preservation profiles (HEARRING group classification) were assessed. Results: All subjects had measurable hearing thresholds at follow-up. No case of complete loss of hearing or minimal hearing preservation was reported at any time point. At activation (Nact = 15), five participants had complete hearing preservation, and ten participants had partial hearing preservation. At the 12M time point (N12m = 6), three participants had complete hearing preservation, and three participants had partial hearing preservation. Mean hearing loss at activation was 11 dB for full range PTA and 25 dB for PTAs low-frequency (125–500 Hz). Conclusions: This study provides the first longitudinal follow-up on associated hearing profiles to the EVO™ electrode array, which are comparable to the literature. However, other studies on larger populations should be performed.Show less >

Audience :

Internationale

Administrative institution(s) :

Université de Lille
Inserm
CHU Lille

Collections :

• Advanced Drug Delivery Systems (ADDS) - U1008

Submission date :

2022-12-08T01:19:57Z
2023-03-01T09:55:09Z